Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Anemia 4Uterine Cervical Neoplasms 2Lung Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Neutropenia 1Neoplasms 1Head and Neck Neoplasms 1Fanconi Anemia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Filgrastim 6pegylated granulocyte colony-stimulating factor 4pegfilgrastim 4Vancomycin 3Etoposide 3Cytarabine 3Cefepime 3Amikacin 3Teicoplanin 2Methotrexate 2Meropenem 2Granulocyte Colony-Stimulating Factor 2Daunorubicin 2Cyclosporine 2Ciprofloxacin 2Ceftazidime 2ziprasidone 1niraparib 1lintuzumab 1leridistim 1fludarabine phosphate 1angiotensin I (1-7) 1Zolpidem 1Warfarin 1Vitamin B 12 1Vincristine 1Vecuronium Bromide 1Transplantation 1Tranexamic Acid 1Tobramycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Cisplatin × Classical hematology × Clear all
NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
160 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡